Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 34 min ago
Peer-reviewedCC BY-NCChemical and Pharmaceutical Bulletin

Comparison of Honokiol Contents in Different Plant Parts of Magnolia obovata Collected at Various Times and Cultivation Sites, Using Honokiol Exhibiting Antiproliferative Activity against Cancer Stem Cells Derived from Human Glioblastoma

Abstract

The bark of Magnolia obovata has long been used as the traditional crude drug "Koboku," and its major constituents, the neolignans honokiol (1) and magnolol (2), exhibit various pharmacological activities, including anticancer effects. We confirmed that 1 exerted antiproliferative activity against cancer stem cells derived from the human glioblastoma cell line U-251 MG. However, because only the bark is utilized as Koboku, its supply is limited, raising concerns regarding production sustainability. Therefore, we quantified 1 and 2 in plant parts, including leaves collected at various times and cultivation sites, to evaluate whether non-bark tissues could serve as supplementary sources of these compounds. Analysis of leaves categorized by length and petioles classified by color in May revealed that shorter leaves (5-10 cm) contained the highest level of 1, exceeding half of that in commercially available Koboku. Quantitative analysis of the bark, leaves, petioles, buds, and seeds from two cultivation sites in September and November showed that the bark consistently contained the highest amounts of 1 and 2. In the examined leaf samples, relatively high levels of both compounds were observed in May, particularly in small leaves, whereas the size-dependent differences among leaves were less evident in September and November. Collectively, these findings suggest that small, early expanded leaves of M. obovata may have potential as a supplementary source of honokiol (1).

Related

  1. Design, synthesis, and in vitro antiproliferative evaluation of dasatinib/HO-1 inhibitor codrugs towards glioblastoma therapy.
    Valeria Pittalà, Loredana Salerno, Valeria Consoli +12
    RSC medicinal chemistryPeer-reviewedCC BYFull textOrganic chemistryEurope PMC
  2. Comparison of One-Dimensional and Quasi-Two-Dimensional Friction Models for Hydraulic Transient Response and Energy Dissipation in Viscoelastic Pipelines at Different Water Temperatures
    Wuhong Li, Qiang Sun, Zongku Liu +1
    ACS OmegaPeer-reviewedCC BY-NC-ND 4.0Full textGeneral chemistryCrossrefEurope PMCEurope PMCPMC
  3. Rational structure-guided identification of a Bcl-2-targeting peptide with antiproliferative effects on colorectal cancer cells
    Xing Jin, Shudan Yang, Qianqian Wang +3
    Journal of enzyme inhibition and medicinal chemistryPeer-reviewedCC BY-NCFull textOrganic chemistryEurope PMC
  4. Benzothiazole–Triazole–Indazole Conjugates: Design, Characterization, and Preliminary In Vitro MTT-Based Antiproliferative Evaluation
    Fatima E. Laghchioua, Maurizio Viale, Renata Silva +6
    Molecules (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral chemistryEurope PMC
  5. A Highly Stable Cyclic (Amino)(Aryl)Nitrenium Radical Dication Exhibiting Temperature-Dependent Radical Bistability Maruti Suryavansi,a Manas Khatua,b,d Bappaditya Goswami,c Apurba Kumar Pal,a Subhas Samanta,*d and K. Geetharani*
    Geetharani K
    ChemRxivPreprintCC BYFull textOrganic chemistryChemRxiv
BibTeX
@article{tsujikawa2026comparison,
  title = {{Comparison of Honokiol Contents in Different Plant Parts of Magnolia obovata Collected at Various Times and Cultivation Sites, Using Honokiol Exhibiting Antiproliferative Activity against Cancer Stem Cells Derived from Human Glioblastoma}},
  author = {Akane Tsujikawa and Kousuke Araki and Tomoe Ohta and Junko Tsukioka and Seikou Nakamura},
  journal = {Chemical and Pharmaceutical Bulletin},
  year = {2026},
  month = sep,
  doi = {10.1248/cpb.c26-00343},
  url = {https://www.jstage.jst.go.jp/article/cpb/74/9/74_c26-00343/_article},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Comparison of Honokiol Contents in Different Plant Parts of Magnolia obovata Collected at Various Times and Cultivation Sites, Using Honokiol Exhibiting Antiproliferative Activity against Cancer Stem Cells Derived from Human Glioblastoma
AU  - Akane Tsujikawa
AU  - Kousuke Araki
AU  - Tomoe Ohta
AU  - Junko Tsukioka
AU  - Seikou Nakamura
PY  - 2026
DA  - 2026/09/25
JO  - Chemical and Pharmaceutical Bulletin
DO  - 10.1248/cpb.c26-00343
UR  - https://www.jstage.jst.go.jp/article/cpb/74/9/74_c26-00343/_article
AB  - The bark of Magnolia obovata has long been used as the traditional crude drug "Koboku," and its major constituents, the neolignans honokiol (1) and magnolol (2), exhibit various pharmacological activities, including anticancer effects. We confirmed that 1 exerted antiproliferative activity against cancer stem cells derived from the human glioblastoma cell line U-251 MG. However, because only the bark is utilized as Koboku, its supply is limited, raising concerns regarding production sustainability. Therefore, we quantified 1 and 2 in plant parts, including leaves collected at various times and cultivation sites, to evaluate whether non-bark tissues could serve as supplementary sources of these compounds. Analysis of leaves categorized by length and petioles classified by color in May revealed that shorter leaves (5-10 cm) contained the highest level of 1, exceeding half of that in commercially available Koboku. Quantitative analysis of the bark, leaves, petioles, buds, and seeds from two cultivation sites in September and November showed that the bark consistently contained the highest amounts of 1 and 2. In the examined leaf samples, relatively high levels of both compounds were observed in May, particularly in small leaves, whereas the size-dependent differences among leaves were less evident in September and November. Collectively, these findings suggest that small, early expanded leaves of M. obovata may have potential as a supplementary source of honokiol (1).
SN  - 1347-5223
SN  - 0009-2363
ER  -